CEN BIOTECH INC Quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD from Q4 2016 to Q3 2022
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
-
Summary
-
Cen Biotech Inc quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate from Q4 2016 to Q3 2022.
- Cen Biotech Inc Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending September 30, 2022 was $8.3M, a 7.79% increase year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Growth (%)